Bills / H.B. 389
H.B. 389 Cannabis Amendments
- Introduced
- House committee
- House vote
- Senate committee
- Senate vote
- Signed into law
What this bill does
This bill restructures the medical cannabis licensing board into a three-member professional board and moves more program work from the Department of Health and Human Services to the Department of Agriculture and Food. It also defines low-THC products sold in licensed facilities as medical cannabis products, along with changes to labeling, a uniform transaction fee, and related rules.
Plain-English summary written by AI from the sponsor’s presentation in committee and on the floor. Check the official text below.
Official description
- amends provisions related to hazardous waste and cannabinoid (hemp) disposal
- requires industrial hemp retailers to check an individual's identification to ensure a purchaser is at least 21 years old
- repeals video surveillance requirements for industrial hemp retailers
- amends provisions related to unlawful acts concerning hemp products
- exempts medical cannabis processors from obtaining an additional license to process hemp products
- creates a fee on medical cannabis purchases for use in enforcement of various laws
- renames the Cannabis Production Establishment and Pharmacy Licensing Advisory Board to the Specialized Product Authority Licensing Board (licensing board)
- reconstitutes the licensing board's membership
- amends provisions related to labeling and packaging
- modifies the licensing board's duties
- moves control of the Qualified Patient Enterprise Fund to the Department of Agriculture and Food (UDAF)
- moves all Department of Health and Human Services duties related to the medical cannabis program to UDAF
- allows medical cannabis processors to make cannabis products with a THC content below .3% (low THC products)
- allows medical cannabis pharmacies to sell low THC products
- includes a coordination clause to address a cross-reference in S.B. 121, Medical Cannabis Program Amendments
- includes a coordination clause with H.B. 385, Specialized Product Sales Amendments, to address the movement of the Qualified Patient Enterprise Fund
What it costs you
- The official fiscal note on residents and businesses:
Enactment of this legislation could cost medical cannabis patients $2,413,900 ongoing beginning in FY 2027 from paying an additional uniform transaction fee on medical cannabis purchases.
From the bill's latest official fiscal note, counting the state's tax funds (General, Income Tax, Education, Uniform School, and Transportation) in the first full budget year after the session. Some bills take effect partway through that year, so later years can be larger; the note shows each year. Household count: U.S. Census Bureau. An average is a starting point, not your bill.
Your legislators on this bill
Enter your address to see what your own representative and senator did on this bill.
Quotes come from the official recordings' automatic captions, which can mishear words. Speakers and summaries are identified by AI and can be wrong. Use the ▶ links to check the recording.
Take action
This bill's session is over, but your legislators still want to hear from you. Ideas that died often come back next year.
Enter your address to get your legislators' contact information and a ready-to-send message about this bill.
Every vote
- 8 yes, 0 no, 6 absentHouse Natural Resources, Agriculture, and Environment Committee: vote to change the bill · Feb 11, 2026Who voted how
- 8 yes, 1 no, 5 absentHouse Natural Resources, Agriculture, and Environment Committee: vote to approve it · Feb 11, 2026Who voted how
- 59 yes, 1 no, 15 absentFinal House vote · Feb 19, 2026Who voted how
- 5 yes, 0 no, 2 absentSenate Health and Human Services Committee: vote to approve it · Feb 25, 2026Who voted how
- 26 yes, 0 no, 3 absentFinal Senate vote · Mar 5, 2026Who voted how
- 72 yes, 1 no, 2 absentHouse vote to accept the other chamber's changes · Mar 5, 2026Who voted how
Hearings and debates
- Feb 11, 2026 House Natural Resources, Agriculture, and Environment Committee▶ WatchRead the transcript (46 turns) →
- Feb 19, 2026 House floor debate▶ WatchRead the transcript (11 turns) →
- Feb 19, 2026 House floor debate▶ WatchRead the transcript (12 turns) →
- Feb 25, 2026 Senate Health and Human Services Committee▶ WatchRead the transcript (9 turns) →
- Mar 5, 2026 Senate floor debate▶ WatchRead the transcript (10 turns) →
- Mar 5, 2026 House floor debate▶ WatchRead the transcript (12 turns) →